PATENT CLAIM ANALYSIS

Application Number: 15744532
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "007100"]

Abstract:
Provided is a composition including a combination of at least one short peptide and at least one peptide dimer, in defined ratio, to which autoantibodies found in elevated levels in schizophrenic patients bind.

Claim (Index 10):
The composition according to  claim 1 , comprising a compound of the general formula (VI) or (VII):\n X\u2014C(O)\u2014CHY\u2014CH 2 \u2014S\u2014S\u2014CH 2 \u2014CHY\u2032\u2014C(O)-LGVVL\u2003\u2003(VI) LVVGL-C(O)\u2014CHY\u2014CH 2 \u2014S\u2014S\u2014CH 2 \u2014CHYLC(O)\u2014X\u2032\u2003\u2003(VII); wherein each of X, X\u2032, Y and Y\u2032, independently of the other, is as defined in  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.28571
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13701177', '15039681', '15994978', '14764419', '09793146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5642515396721887
- 35 USC 102 Novelty (BERT): 0.4934810530069656
- Combined Prediction Score: 0.5571744910056664
- Mean Citation Score: 181.942498
- Max Citation Score: 186.26022
- Similarity Product: 115.08655108386758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test